Involvement of mTOR in CXCL12 mediated T cell signaling and migration

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Munk, Rachel ^a   Ghosh, Paritosh ^a   Ghosh, Manik C ^a   Saito, Takeshi ^a   Xu, Mai ^a   Carter, Arnell ^a   Indig, Fred ^a   Taub, Dennis D ^a   Longo, Dan L ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN P70; RAPAMYCIN; SHORT HAIRPIN RNA; STROMAL CELL DERIVED FACTOR 1; CXCL12 PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; LENTIVIRINAE; LEUKEMIA CELL LINE; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE; VIRAL GENE DELIVERY SYSTEM; ANIMAL; CELL CULTURE; CELL MOTION; CONFOCAL MICROSCOPY; CYTOLOGY; DRUG ANTAGONISM; GENETICS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

MAMMALIA;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CXCL12; HUMANS; MICE; MICROSCOPY, CONFOCAL; SIGNAL TRANSDUCTION; SIROLIMUS; T-LYMPHOCYTES; TOR SERINE-THREONINE KINASES;

EID: 80052608274     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024667     Document Type: Article

References (29)

1. Vicente-Manzanares M, Cruz-Adalia A, Martin-Cofreces NB, Cabrero JR, Dosil M, et al. (2005) Control of lymphocyte shape and the chemotactic response by the GTP exchange factor Vav. Blood 105: 3026-3034.
2. Voermans C, Anthony EC, Mul E, van der Schoot E, Hordijk P, (2001) SDF-1-induced actin polymerization and migration in human hematopoietic progenitor cells. Exp Hematol 29: 1456-1464.
3. Vila-Coro AJ, Rodriguez-Frade JM, Martin De Ana A, Moreno-Ortiz MC, Martinez AC, et al. (1999) The chemokine SDF-1alpha triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. Faseb J 13: 1699-1710.
4. Zhang XF, Wang JF, Matczak E, Proper JA, Groopman JE, (2001) Janus kinase 2 is involved in stromal cell-derived factor-1alpha-induced tyrosine phosphorylation of focal adhesion proteins and migration of hematopoietic progenitor cells. Blood 97: 3342-3348.
5. Tilton B, Ho L, Oberlin E, Loetscher P, Baleux F, et al. (2000) Signal transduction by CXC chemokine receptor 4. Stromal cell-derived factor 1 stimulates prolonged protein kinase B and extracellular signal-regulated kinase 2 activation in T lymphocytes. J Exp Med 192: 313-324.
6. Kremer KN, Humphreys TD, Kumar A, Qian NX, Hedin KE, (2003) Distinct role of ZAP-70 and Src homology 2 domain-containing leukocyte protein of 76 kDa in the prolonged activation of extracellular signal-regulated protein kinase by the stromal cell-derived factor-1 alpha/CXCL12 chemokine. J Immunol 171: 360-367.
7. Kumar A, Humphreys TD, Kremer KN, Bramati PS, Bradfield L, et al. (2006) CXCR4 physically associates with the T cell receptor to signal in T cells. Immunity 25: 213-224.
8. Hashimoto I, Koizumi K, Tatematsu M, Minami T, Cho S, et al. (2008) Blocking on the CXCR4/mTOR signalling pathway induces the anti-metastatic properties and autophagic cell death in peritoneal disseminated gastric cancer cells. Eur J Cancer 44: 1022-1029.
9. Murooka TT, Rahbar R, Platanias LC, Fish EN, (2008) CCL5-mediated T-cell chemotaxis involves the initiation of mRNA translation through mTOR/4E-BP1. Blood 111: 4892-4901.
10. Wang J, Lu Y, Koch AE, Zhang J, Taichman RS, (2008) CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway. Cancer Res 68: 10367-10376.
11. Sarbassov DD, Ali SM, Sabatini DM, (2005) Growing roles for the mTOR pathway. Curr Opin Cell Biol 17: 596-603.
12. Harris TE, Lawrence JC Jr, (2003) TOR signaling. Sci STKE 2003 pp. re15.
13. Finlay D, Cantrell D, (2010) Phosphoinositide 3-kinase and the mammalian target of rapamycin pathways control T cell migration. Ann N Y Acad Sci 1183: 149-157.
14. Sinclair LV, Finlay D, Feijoo C, Cornish GH, Gray A, et al. (2008) Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nat Immunol 9: 513-521.
15. Zhang S, Readinger JA, DuBois W, Janka-Junttila M, Robinson R, et al. (2011) Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production. Blood 117: 1228-1238.
16. Garcia-Martinez JM, Moran J, Clarke RG, Gray A, Cosulich SC, et al. (2009) Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR). Biochem J 421: 29-42.
17. Feldman ME, Apsel B, Uotila A, Loewith R, Knight ZA, et al. (2009) Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS Biol 7: e38.
18. Thoreen CC, Kang SA, Chang JW, Liu Q, Zhang J, et al. (2009) An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J Biol Chem 284: 8023-8032.
19. Cloughesy TF, Yoshimoto K, Nghiemphu P, Brown K, Dang J, et al. (2008) Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma. PLoS Med 5: e8.
20. Sallusto F, Lanzavecchia A, Mackay CR, (1998) Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 19: 568-574.
21. Ward SG, (2006) T lymphocytes on the move: chemokines, PI 3-kinase and beyond. Trends Immunol 27: 80-87.
22. Manning BD, Tee AR, Logsdon MN, Blenis J, Cantley LC, (2002) Identification of the Tuberous Sclerosis Complex-2 Tumor Suppressor Gene Product Tuberin as a Target of the Phosphoinositide 3-Kinase/Akt Pathway. Molecular Cell 10: 151-162.
23. Manning BD, Cantley LC, (2007) AKT/PKB signaling: navigating downstream. Cell 129: 1261-1274.
24. Karin N, (2010) The multiple faces of CXCL12 (SDF-1alpha) in the regulation of immunity during health and disease. J Leukoc Biol 88: 463-473.
25. Ma XM, Blenis J, (2009) Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol 10: 307-318.
26. Norman MR, Thompson EB, (1977) Characterization of a Glucocorticoid-sensitive Human Lymphoid Cell Line. Cancer Research 37: 3785-3791.
27. Ghosh MC, Baatar D, Collins G, Carter A, Indig F, et al. (2009) Dexamethasone augments CXCR4-mediated signaling in resting human T cells via the activation of the Src kinase Lck. Blood 113: 575-584.
28. Ghosh MC, Collins GD, Vandanmagsar B, Patel K, Brill M, et al. (2009) Activation of Wnt5A signaling is required for CXC chemokine ligand 12-mediated T-cell migration. Blood 114: 1366-1373.
29. Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray P, et al. (2002) Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 1: 279-288.